Trial | NCT01868841  Report issue

Title

123-I mIBG (AdreView) Heart-to-Mediastinal (H/M) Ratio and SPECT Imaging on a Small Field of View-High Efficiency Cardiac SPECT System
123-I mIBG (AdreView) Heart-to-Mediastinal (H/M) Ratio and SPECT Imaging

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    iobenguane (123i) ...

  • Study Participants

    45
The purpose of this study is to demonstrate correlation of the H/M ratio of AdreView when derived from a large field of view Anger SPECT system and from a small field of view high sensitivity (CZT) SPECT system.
Study Started
Dec 31
2013
Primary Completion
Sep 30
2014
Study Completion
Oct 31
2014
Last Update
Jan 11
2018

Drug AdreView

10 millicurie of AdreView (123I-mIBG)

Other Single Photon Emission Computed Tomography

  • Other names: SPECT

Adreview LFOV SPECT Imaging followed by SFOV-HE Imaging Active Comparator

SPECT imaging of 10 millicurie of Adreview

AdreView SFOV-HE SPECT Imaging followed by LFOV Imaging Active Comparator

SPECT imaging of 10 millicurie of Adreview

Criteria 

Inclusion Criteria:

New York Heart Association Class II or III Heart Failure
Left ventricular ejection fraction less than or equal to 35%

Exclusion Criteria:

Uncompensated heart failure
Recent hospitalization within 30 days of cardiac related indications
No Results Posted